A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Resources
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Resources Index
Whitepapers
How to Maximize the Strategic Value of Formulations Data in Pharma
This whitepaper discusses how pharmaceutical companies can maximize the strategic value of formulations data to shorten development times, stay ahead of competition, and position themselves for success.
Press Releases
CAS Releases Special Report Highlighting COVID-19 Diagnostic Test Research
CAS has issued a special report in ACS Central Science titled “Assay Techniques and Test Development for COVID-19 Diagnosis.” This report provides a detailed overview of COVID-19 diagnostic tests, trends, and resources.
Articles
Assay Techniques and Test Development for COVID-19 Diagnosis
To provide a better understanding and comparison of the diagnostic tests available in the fight against COVID-19, CAS has produced a report summarizing the basic principles of molecular and serological assays being used in diagnostic tests for SARS-CoV-2. The report highlights recent advancements in testing technologies and provides a high-level view of currently available diagnostic tests.
Blog
Recent advances support scalability of COVID-19 diagnostic testing
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to grip the world. Large-scale testing is required for countries to successfully limit infections and mortality rates, and is key to easing many lockdown restrictions. In this unprecedented crisis, every hour matters when it comes to identifying and preventing further spread of this virus.
Case Studies
Curated Training Sets for Innovative AI Predictions
Utilizing only internal data can lead to the lack of specific electronic, structure and device properties required to generate innovative machine learning predictions. Learn how one company turned to custom-curated data to expand a limited view of the scientific landscape.
Blog
Targeting ACE2 – Closing COVID-19’s cellular doorway
Since the outbreak of COVID-19, caused by SARS-CoV-2 virus, scientists have been racing to understand it. Extensive research has been devoted to identifying viable genes and proteins as targets for therapeutic agents. One particular protein that has drawn considerable attention is the human cell’s viral receptor, angiotensin-converting enzyme 2 (ACE2).
Articles
Getting Started in Data-Driven Chemical and Materials Discovery
Are you just getting started or ramping up machine learning for chemical and materials research? In this webinar, the panelists will discuss how to prepare for a new informatics project by exploring how to build useful data sets, identify missing capabilities, and communicate expectations.
Blog
In This Together: CAS Joining Forces with Researchers and Data Scientists to Accelerate COVID-19 Treatments
With millions of confirmed COVID-19 cases, and many more likely going untested, researchers around the world are racing to find solutions to this daunting challenge. Approved drugs are being explored as treatments for those afflicted, vaccines to prevent the long-term spread are in development, as well as many other efforts beyond drug discovery. To keep frontline healthcare professionals safe, manufacturers are reimagining production processes to make critical supplies, such as hand sanitizer and mask filters, testing methods are being optimized to be faster and more accurate, materials for new germ-resistant masks are being developed and new systems to sterilize medical equipment are being designed.
Press Releases
CAS Releases Open Access Dataset of Antiviral Chemical Compounds to Aid COVID-19 Discovery and Analysis
CAS has released an open access dataset of chemical compounds with known or potential antiviral activity to support COVID-19 research and data mining. The dataset contains nearly 50,000 chemical substances assembled from the CAS REGISTRY® that have antiviral activity reported in published literature or are structurally similar to known antivirals. Available to download now.